Noteworthy - February 2021

 

Jennifer Burrows named chief executive, Providence St. Vincent Medical Center

Jennifer Burrows, RN, has accepted the role of chief executive of Providence St. Vincent Medical Center, replacing Janice Burger, who retired in late 2020. Jennifer has served as chief clinical and nursing officer for Oregon since the fall of 2019. Jennifer has helped lead Providence Oregon through this very challenging time of COVID, while remaining laser-focused on clinical excellence and keeping caregivers safe. She begins her new role on March 1.

Prior to her regional CNO role, Jennifer was chief nursing officer at Providence St. Vincent for five years. She began her career as a nurse in labor and delivery, and she quickly was drawn to leadership roles where she could shape the way patients are cared for. From 2002 to 2014 Jennifer was vice president of patient care services at Sentara health care locations in Virginia, including Norfolk General Hospital, a 525-bed quaternary medical center.

 

Providence St. Vincent named a Top 50 Hospital

Providence St. Vincent Medical Center has been named a Top 50 Hospital by Healthgrades, a national organization that ranks hospitals based on clinical outcomes. This distinction places Providence St. Vincent in the top 1% of hospitals in the U.S., and the only hospital in Oregon to achieve this honor.

“I’m so proud of our providers and caregivers and the outstanding work they do each and every day for our patients, their families and the communities we serve,” says Raymond Moreno, M.D., chief medical officer at Providence St. Vincent Medical Center. “This recognition from Healthgrades is particularly meaningful after the challenging year we’ve just had with COVID-19. Quality and safety have never been more important – both to our patients and to our caregivers.”

https://www.beckershospitalreview.com/rankings-and-ratings/healthgrades-50-top-hospitals-for-2021.html
 


Providence Cancer Institute hosts April 8 virtual Advances in Cancer Immunotherapy program

Learn about the most recent clinical advancements and FDA approvals in cancer immunotherapy from leading local authorities in tumor immunology and cancer immunotherapy. This program is presented in collaboration with the Society for Immunotherapy of Cancer and is designed specifically for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team. Registration is free for health care providers. CME, CNE, CPE and MOC credits are available. Read more about this program 

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.

More Content by Providence inScope Content Team
Previous Article
Research focuses on how COVID affects pregnancy, new birth parents
Research focuses on how COVID affects pregnancy, new birth parents

Providence Women and Children’s Services is partnering to conduct new research on how pregnant people and t...

Next Article
Successful heart transplants performed; hospital wing renamed
Successful heart transplants performed; hospital wing renamed

Providence Heart Institute has performed five heart transplants since July, with plans to perform up to 12 ...